ASTI — Aquarius Surgical Technologies Cashflow Statement
0.000.00%
- CA$0.55m
- CA$5.08m
- CA$0.21m
Annual cashflow statement for Aquarius Surgical Technologies, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.61 | -1.81 | -0.859 | -0.723 | -0.758 |
Depreciation | |||||
Non-Cash Items | 0.362 | 0.987 | 0.192 | 0.107 | 0.289 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.167 | 0.278 | 0.504 | 0.685 | 0.186 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -0.951 | -0.409 | -0.112 | 0.077 | -0.253 |
Capital Expenditures | -0.123 | -0.1 | -0.005 | 0 | -0.004 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.036 | 0 | — | — | — |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -0.087 | -0.1 | -0.005 | 0 | -0.004 |
Financing Cash Flow Items | -0.086 | 0 | -0.024 | -0.024 | -0.024 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.02 | 0.55 | 0.13 | -0.113 | 0.242 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.02 | 0.041 | 0.012 | -0.036 | -0.015 |